Related references
Note: Only part of the references are listed.Synthesis of 1-Substituted 3-Aryl-5-aryl(hetaryl)-2-pyrazolines and Study of Their Antitumor Activity
Braulio Insuasty et al.
ARCHIV DER PHARMAZIE (2012)
Synthesis, Cytotoxic Properties and Tubulin Polymerization Inhibitory Activity of Novel 2-Pyrazoline Derivatives
Mohamed Abdel-Aziz et al.
ARCHIV DER PHARMAZIE (2012)
Synthesis, biological evaluation, and docking studies of 3-(substituted)-aryl-5-(9-methyl-3-carbazole)-1H-2-pyrazolines as potent anti-inflammatory and antioxidant agents
Babasaheb P. Bandgar et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2012)
Three-dimensional quantitative structure activity relationship (QSAR) of cytotoxic active 3,5-diaryl-4,5-dihydropyrazole analogs: a comparative molecular field analysis (CoMFA) revisited study
Abdel-Sattar S. Hamad Elgazwy et al.
CHEMISTRY CENTRAL JOURNAL (2012)
Recent advances in the therapeutic applications of pyrazolines
Mohamed R. Shaaban et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2012)
Synthesis anti-inflammatory and anticancer activity evaluation of some pyrazole and oxadiazole derivatives
Sham M. Sondhi et al.
MEDICINAL CHEMISTRY RESEARCH (2012)
Simple pyrazoline and pyrazole turn on fluorescent sensors selective for Cd2+ and Zn2+ in MeCN
Alexander Ciupa et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2012)
Synthesis of tetrazole-isoxazoline hybrids as a new class of tubulin polymerization inhibitors
Ahmed Kamal et al.
MEDCHEMCOMM (2012)
Synthesis of Some Pyrazolines and Pyrimidines Derived from Polymethoxy Chalcones as Anticancer and Antimicrobial Agents
Sherif A. F. Rostom et al.
ARCHIV DER PHARMAZIE (2011)
A rational approach for the design and synthesis of 1-acetyl-3,5-diaryl-4,5-dihydro(1H)pyrazoles as a new class of potential non-purine xanthine oxidase inhibitors
Kunal Nepali et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2011)
Synthesis, characterization and cytotoxicity of the gold(III) complexes of 4,5-dihydropyrazole-1-carbothioamide derivatives
Shuxiang Wang et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2011)
2-Anilinonicotinyl linked 1,3,4-oxadiazole derivatives: Synthesis, antitumour activity and inhibition of tubulin polymerization
Ahmed Kamal et al.
MEDCHEMCOMM (2011)
Design, synthesis and antiproliferative activity of urocanic-chalcone hybrid derivatives
Alexander Ciupa et al.
MEDCHEMCOMM (2011)
Synthesis and biological evaluation of pyrazole derivatives containing thiourea skeleton as anticancer agents
Peng-Cheng Lv et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2010)
Synthesis and molecular modelling studies of prenylated pyrazolines as MAO-B inhibitors
Rossella Fioravanti et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
Towards development of selective and reversible pyrazoline based MAO-inhibitors: Synthesis, biological evaluation and docking studies
Anasuya Sahoo et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
Novel chalcones and 1,3,5-triphenyl-2-pyrazoline derivatives as antibacterial agents
Ponnurengam Malliappan Sivakumar et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2010)
Synthesis and antimalarial evaluation of 1, 3, 5-trisubstituted pyrazolines
Badri Narayan Acharya et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2010)
Synthesis and biological evaluation of N-substituted-3,5-diphenyl-2-pyrazoline derivatives as cyclooxygenase (COX-2) inhibitors
Rossella Fioravanti et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2010)
The synthesis, X-ray crystal structure and optical properties of novel 1,3,5-triaryl pyrazoline derivatives
Zhong-Liang Gong et al.
JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY A-CHEMISTRY (2010)
Antivascular and anticancer activity of dihalogenated A-ring analogues of combretastatin A-4
Thomas M. Beale et al.
MEDCHEMCOMM (2010)
Design, synthesis and biological evaluation of imidazopyridine/pyrimidine-chalcone derivatives as potential anticancer agents
Ahmed Kamal et al.
MEDCHEMCOMM (2010)
Synthesis, antitubercular activity and docking study of novel cyclic azole substituted diphenyl ether derivatives
Suvarna G. Kini et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2009)
Synthesis and screening of anti-cancer, antioxidant, and anti-inflammatory activities of novel galloyl pyrazoline derivatives
Mohamed Abdel-Aziz et al.
PHARMACEUTICAL BIOLOGY (2009)
A new therapeutic approach in Alzheimer disease:: Some novel pyrazole derivatives as dual MAO-B inhibitors and antiinflammatory analgesics
Nesrin Goekhan-Kelekci et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2007)
The NCI60 human tumour cell line anticancer drug screen
Robert H. Shoemaker
NATURE REVIEWS CANCER (2006)
Synthesis and molecular modelling of novel substituted-4,5-dihydro-(1H)-pyrazole derivatives as potent and highly selective monoamine oxidase-A inhibitors
F Chimenti et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2006)
Synthesis, molecular modeling studies, and selective inhibitory activity against monoamine oxidase of 1-thiocarbamoyl-3,5-diaryl-4,5-dihydro-(1H)-pyrazole derivatives
F Chimenti et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Synthesis and selective inhibitory activity of 1-acetyl-3,5-diphenyl-4,5-dihydro-(1H)-pyrazole derivatives against monoamine oxidase
F Chimenti et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
Two-step synthesis of β-alkyl chalcones and their use in the synthesis of 3,5-diaryl-5-alkyl-4,5-dihydropyrazoles
CD Cox et al.
TETRAHEDRON LETTERS (2004)
Enantiomers of C5-chiral 1-acetyl-3,5-diphenyl-4,5-dihydro-(1H)-pyrazole derivatives:: Analytical and semipreparative HPLC separation, chiroptical properties, absolute configuration, and inhibitory activity against monoamine oxidase
R Cirilli et al.
CHIRALITY (2004)
Structural requirements for the interaction of combretastatins with tubulin: how important is the trimethoxy unit?
K Gaukroger et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2003)
Anti-HIV and cytotoxic activities of Ru(II)/Ru(III) polypyridyl complexes containing 2,6-(2′-benzimidazolyl)-pyridine/chalcone as co-ligand
L Mishra et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2001)
Share Paper
